Alliance is still best way to sustain innovation, drug experts say

04/8/2010 | Boston Globe (tiered subscription model), The

Pharmaceutical and biotech veterans agreed that partnership between companies is the best approach to sustaining innovation in drug development amid generic competition and financial pressure. To reduce the risk of investing in compounds that might not be successful, drug developers are learning to "experiment with a growing range of new tools and approaches to weed out unpromising drug candidates earlier, speed development and reduce development costs," said Kenneth Kaitin, director of the Tufts Center for the Study of Drug Development.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Santa Clara, CA
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA